Solstice CEO honored with LLS's John Engdahl Award

Solstice's Chief Executive Officer Dr. Leonard Weiss has been honored by the Leukemia & Lymphoma Society with its John Engdahl Award. The award was established in recognition of John's dreams and his accomplishments of running and raising much needed funds for the Society. These awards are given annually to Team In Training participants who raise more than $5,000 for their event and $1,200 for Fast Track events or Healthy Start programs.

John Engdahl Awards are also given to those participants who run in the Boston Marathon and raise $10,000 or more and qualified/waivered runners who raise $5,000. Dr. Weiss, who was on the LLS's 2015 marathon team and also completed the race, raised over $34,000 for LLS.

This award is a tribute to the marathon that every blood cancer survivor runs, to the challenges of treatment and to the hope of a cure for leukemia, lymphoma, Hodgkin's disease and myeloma.

"I want to express my heartfelt gratitude for being named the recipient of this year's John Engdahl award," said Dr. Weiss. "My success, as well as the success of all of my teammates, is a true testimony to the Society, specifically those individuals who supported the Boston Marathon fundraising event. There is no doubt in my mind that the level of success and passion that was exuded by all was a direct result of all of the 'behind the scenes' support that we received."

Source:

Solstice

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-powered tool predicts gene activity in cancer cells from biopsy images